Patient Centricity

At Boehringer Ingelheim, we put patients first in everything we do. Patients inspire us in our mission to lead the science that creates breakthrough therapies. Our goal is to serve people through research into diseases with unmet needs and the provision of new therapies and healthcare solutions to transform the lives of patients. As an independent and family-owned company, we have the freedom to pursue our long-term vision, to make transformative therapies for life-enhancing healthcare improvements.

Mutual benefit: Patient centricity in clinical trials

Uli Broedl and Bronwyn Lewis share what they learnt from a successful patient organization collaboration on clinical trial design.

Related Content

Woman sitting on a table talking about her experiences of the A life in day programme
Lung Cancer

24 hours in the shoes of a lung cancer patient

The patient experience "A life in a day"  aims to deepen our understanding of  the challenges faced by those living with severe diseases.
Read more
Carinne in conversation with two rare disease experts, talking about the importance of treatment options and awareness of rare diseases.
GPP

“Rare diseases are quite common”

Individually, they may be rare. All together they affect millions.